Acadia Pharmaceuticals (ACAD) Return on Assets (2011 - 2026)

Acadia Pharmaceuticals' Return on Assets history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets eased to 0.0% in Q1 2026 per ACAD's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2024 and bottomed at 0.0% in Q3 2022.
• The 5-year median for Return on Assets is 0.0% (2024), against an average of 0.0%.
• Biggest YoY gain for Return on Assets was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• Year by year, Return on Assets stood at 0.0% in 2022, then jumped by 76 bps to 0.0% in 2023, then jumped by 363 bps to 0.0% in 2024, then plunged by 51 bps to 0.0% in 2025, then dropped by 17 bps to 0.0% in 2026.
• Per Business Quant, the three latest ACAD Return on Assets figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).